Article Text

PDF
Original article
A new seipin-associated neurodegenerative syndrome
  1. Encarna Guillén-Navarro1,
  2. Sofía Sánchez-Iglesias2,
  3. Rosario Domingo-Jiménez3,
  4. Berta Victoria2,
  5. Alejandro Ruiz-Riquelme2,
  6. Alberto Rábano4,
  7. Lourdes Loidi5,
  8. Andrés Beiras6,
  9. Blanca González-Méndez2,
  10. Adriana Ramos2,
  11. Vanesa López-González1,
  12. María Juliana Ballesta-Martínez1,
  13. Miguel Garrido-Pumar7,
  14. Pablo Aguiar7,
  15. Alvaro Ruibal7,
  16. Jesús R Requena2,
  17. David Araújo-Vilar2
  1. 1Unit of Medical Genetics and Dysmorphology, Division of Pediatrics, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
  2. 2Department of Medicine, School of Medicine and CIMUS Biomedical Research Institute, University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain
  3. 3Section of Neuropediatrics, Division of Pediatrics, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
  4. 4Neuropathology Department and Tissue Bank, Fundación CIEN, Madrid, Spain
  5. 5Fundación Galega de Medicina Xenómica, Santiago de Compostela, Spain
  6. 6Department of Pathology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  7. 7Division of Nuclear Medicine, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
  1. Correspondence to Dr David Araújo-Vilar, Department of Medicine-IDIS, CIMUS-Facultade de Medicina, University of Santiago de Compostela, Avda de Barcelona s/n, Santiago de Compostela 15707, Spain; david.araujo{at}usc.es

Abstract

Background Seipin/BSCL2 mutations can cause type 2 congenital generalised lipodystrophy (BSCL) or dominant motor neurone diseases. Type 2 BSCL is frequently associated with some degree of intellectual impairment, but not to fatal neurodegeneration. In order to unveil the aetiology and pathogenetic mechanisms of a new neurodegenerative syndrome associated with a novel BSCL2 mutation, six children, four of them showing the BSCL features, were studied.

Methods Mutational and splicing analyses of BSCL2 were performed. The brain of two of these children was examined postmortem. Relative expression of BSCL2 transcripts was analysed by real-time reverse transcription-polymerase chain reaction (RT-PCR) in different tissues of the index case and controls. Overexpressed mutated seipin in HeLa cells was analysed by immunofluorescence and western blotting.

Results Two patients carried a novel homozygous c.985C>T mutation, which appeared in the other four patients in compound heterozygosity. Splicing analysis showed that the c.985C>T mutation causes an aberrant splicing site leading to skipping of exon 7. Expression of exon 7-skipping transcripts was very high with respect to that of the non-skipped transcripts in all the analysed tissues of the index case. Neuropathological studies showed severe neurone loss, astrogliosis and intranuclear ubiquitin(+) aggregates in neurones from multiple cortical regions and in the caudate nucleus.

Conclusions Our results suggest that exon 7 skipping in the BSCL2 gene due to the c.985C>T mutation is responsible for a novel early onset, fatal neurodegenerative syndrome involving cerebral cortex and basal ganglia.

  • Clinical genetics
  • Movement disorders (other than Parkinsons)
  • Neurology
  • Molecular genetics
  • Epilepsy and seizures

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.